August 11, 2023
FDA: Class I recall of Cardiosave Hybrid, Rescue IABPs
Editor's Note
The Food and Drug Administration (FDA), on August 10, identified the recall by Datascope/Maquet/Getinge of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious.
The recall was initiated because the pumps may shut down unexpectedly due to electrical failures in the Power Management Board or Solenoid Board (Power Source Path).
The company reports 26 complaints, no injuries, and no deaths associated with this issue.
Distribution dates were March 6, 2012, to May 19, 2023.
Free Daily News
- Session: Riding the Wave—Considerations to Making Anesthesia Profitable in Today's Labor Market
- Session: Surfs Up—Rolling Out the OAS CAHPS Survey
- Montana legislators' prior authorization reform push mirrors national trends
- States push to expand nurse practice authority
- Oregon bill seeks to ban AI from using ‘nurse’ title amid patient safety concerns
- Study: Mechanical heart valves outperform biological for long-term survival in middle-aged patients
- Study: Virtual reality reduces preoperative anxiety in heart surgery patients
- CABG, TAVR drive hospital revenue despite cost variations
- Rural hospital closures drive up surgical travel times and costs
- Human trafficking in healthcare supply chains often underrecognized, expert argues
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement